Fly out of Entebbe this week and you'll fill in a passenger locator form before you board. That's one line in a much longer list Uganda put out yesterday.
Welcome to Ebola Watch. It's Friday, November 20th. We start with Uganda's new border and travel directives, and what they mean if you're headed that way. Then, a plan from the vaccine partners for how Bundibugyo vaccines would actually reach people once one is shown to work.
Samuel Kamugisha, writing in Uganda's Pearl Times, quoting the health ministry statement signed by Permanent Secretary Dr Diana Atwine:
With the current heightened surveillance, the Ministry has observed continued movement of people across our borders, including through ungazetted crossing points, which has increased the risk of the disease entering Uganda and spreading to our communities and to other countries
Ungazetted crossing points. Plain English, please.
Unofficial crossings. The statement is dated Thursday, November 19th, and takes immediate effect. Yesterday we covered the police letter enforcing the gathering ban. This goes a lot further.
Start with travel. That's what changes people's plans.
Three pieces. At Entebbe International Airport, screening is stepped up for arriving and departing passengers, and every air traveller must complete a passenger locator form before boarding, to support contact tracing if there's a suspected exposure. Airlines and other operators found knowingly carrying unauthorised or improperly documented travellers will be sanctioned. And Ugandans returning from Congo get a mandatory health risk assessment, then 21 days of quarantine or monitored self-isolation.
So a visitor flying in gets a form and screening. A Ugandan coming home from Congo gets three weeks.
That's how it reads. It sets no quarantine rule for foreign visitors coming from Congo, so we won't invent one. Check with your airline before you fly.
On Thursday we couldn't say how many districts were covered. Can we now?
We have a count, but still no map. The Nile Post and the Daily Monitor both report 34 designated high-risk districts. Day scholars can't move between Congo and those districts in either direction, and boarding students with possible exposure must finish 21 days of quarantine in designated facilities before returning to school. None of the coverage we've read lists the districts by name.
Thirty-four districts is a lot of border to police. What else is in there?
Humanitarian workers need clearance from the Director General of Health Services before crossing, and so does any transfer of a body into or out of Uganda. New arrivals in a high-risk district must be reported to the Local Council chairperson, and hotels must keep guest registers. Anyone who crosses illegally, or helps someone do it, faces prosecution or penalties.
The humanitarian clearance gives me pause. Those are exactly the people the response needs moving.
It's a fair question for the ministry, and the statement doesn't say how long clearance takes. What's clear is the target: informal movement. That lines up with IOM's figure earlier this month, that 95 percent of confirmed cases found along Congo's mobility corridors were on informal routes.
From CEPI, in a statement published Thursday:
For safe and effective vaccines to reach the people who need them as quickly as possible, planning for post-trial access must happen alongside research and development, not after it.
There's no Bundibugyo vaccine yet. Why plan the rollout now?
That's CEPI's whole argument: plan regulation, manufacturing, financing and delivery now, alongside the research. The Vaccine Access Roadmap comes from the vaccine pillar of the Continental Incident Management Support Team, and it was co-developed by Africa CDC, CEPI, Gavi, WHO and UNICEF.
What does it actually ask for?
Ten recommendations. A few stand out. Prepare urgently for any expanded access or compassionate use. Streamline regulatory pathways and set out the order of national and global authorisations. Don't let product liability and indemnification become a barrier. And define and communicate how potential future vaccines would be allocated should the outbreak expand beyond Congo.
So, who gets it first if there isn't enough.
Right, though the roadmap asks partners to lay out their assumptions rather than settle it now. It also wants special access approaches for humanitarian populations. A dose that can't legally or practically reach a displacement camp isn't protecting anyone there.
Expanded access. Isn't that MSF's Ervebo fight?
It overlaps, but the roadmap doesn't name Ervebo. Actualité.cd reports MSF is still pressing to lift the research-only limits on Ervebo, which was developed against the Zaire species, and repeats MSF's figure that only 70,000 of the 500,000 doses Congo requested in August were made available. We still haven't found any published outcome from Tuesday's SAGE meeting.
And the strain-specific trials?
WHO's plan remains Phase 2 in Bunia on Thursday the 26th or Friday the 27th. The Emergency Manager's Weekly Report says WHO delivered cold-chain equipment to Bunia for the Tumaini trial on Wednesday, including six ultra-low-temperature freezers.
Any movement on the numbers?
ACP reports North Kivu recorded 36 new confirmed cases on November 16th, with 78 percent of active contacts being monitored. And WHO's updated temporary recommendations haven't appeared in anything we've read yet.
If Ebola Watch has become part of your weekday routine, take ten seconds to rate or review the show in your podcast app. It helps the next person looking for straight answers find us.
We're off for the weekend. The next episode is Monday, November 23rd, and we'll be watching for WHO's recommendations and for a named list of Uganda's 34 districts.
Ebola Watch comes to you from Lantern Podcasts. Have a good weekend.